Immunomedics Inc (IMMU) 3.27 $IMMU How These Bi
Post# of 273254
Posted On: 09/25/2016 7:13:37 AM
Immunomedics Inc (IMMU) 3.27 $IMMU
How These Biotech Stocks are Faring? -- Immunomedics, Sequenom, INSYS Therapeutics, and Regulus Therapeutics
PR Newswire - Thu Sep 08, 6:59AM CDT
Biotechnology is well known for cycling between booms and busts, making it both an interesting and intimidating space to navigate. It is a place where investors either come out soaring to the top or the other way around. This morning, Stock-Callers.com directs its attention to the following equities: Immunomedics Inc. (NASDAQ: IMMU), Sequenom Inc. (NASDAQ: SQNM), INSYS Therapeutics Inc. (NASDAQ: INSY), and Regulus Therapeutics Inc. (NASDAQ: RGLS). Register now and get full and free access to our downloadable research reports on these stocks at: http://stock-callers.com/registration
INSY: 12.56 (-0.32), SQNM: 2.39 (-0.01), IMMU: 3.27 (-0.03), RGLS: 3.45 (+0.03)
Immunomedics to Present at Upcoming Investor Conferences
GlobeNewswire - Wed Aug 31, 6:00AM CDT
Immunomedics, Inc. (Nasdaq:IMMU) today announced that the Company will present at three upcoming investor conferences:
IMMU: 3.27 (-0.03)
Preclinical Study on Enhancing Sacituzumab Govitecan (IMMU-132) Activity in SN-38-Resistant Cancer Cells Published
GlobeNewswire - Thu Aug 18, 6:00AM CDT
Immunomedics, Inc. (Nasdaq:IMMU) today announced that adding an inhibitor of ATP-binding cassette (ABC) transporters to sacituzumab govitecan, the Company's lead antibody-drug conjugate (ADC) for solid cancer therapy, increased the median survival of mice bearing a SN-38-resistant human gastric cancer cell line. Results from this preclinical study were published in Molecular Cancer Therapeutics.
IMMU: 3.27 (-0.03)
Immunomedics Announces Conference Call And Webcast For Fourth Quarter And Fiscal Year 2016 Financial Results
GlobeNewswire - Thu Aug 11, 6:00AM CDT
Immunomedics, Inc., (Nasdaq:IMMU) today announced that it will host a conference call and live audio webcast on Wednesday, August 17, 2016 at 5:00 p.m. Eastern Time to discuss financial results for the fourth quarter and fiscal year 2016, and review key clinical developments and future planned activities.
IMMU: 3.27 (-0.03)
DEADLINE TODAY: Khang & Khang LLP Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Aug 08, 10:03AM CDT
IRVINE, CA / ACCESSWIRE / August 8, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU). Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive (the "Class Period" , are encouraged to contact the Firm prior to the August 8, 2016, lead plaintiff motion deadline.
IMMU: 3.27 (-0.03)
FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics Inc. (IMMU) and Lead Plaintiff Deadline - August 8, 2016
ACCESSWIRE - Mon Aug 08, 9:16AM CDT
NEW YORK, NY / ACCESSWIRE / August 8, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against of Immunomedics, Inc. ("Immunomedics" or the "Company" (NASDAQGM: IMMU). The class action has been filed in the United States District Court, District of New Jersey, on behalf of a class consisting of all persons or entities who purchased Immunomedics common stock between April 20, 2016 and June 2, 2016 inclusive (the "Class Period" .
IMMU: 3.27 (-0.03)
IMMUNOMEDICS 72 HOUR DEADLINE ALERT: APPROXIMATELY 72 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS of Deadline in Class Action Lawsuit Against Immunomedics Inc. - IMMU
GlobeNewswire - Fri Aug 05, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until August 8, 2016 to file lead plaintiff applications in a securities class action lawsuit against Immunomedics Inc. (Nasdaq:IMMU). Investor losses must relate to purchases of the Company's securities between April 20, 2016 and June 2, 2016. This action is pending in the United States District Court for the District of New Jersey.
IMMU: 3.27 (-0.03)
APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Aug 04, 10:44AM CDT
LOS ANGELES, CA / ACCESSWIRE / August 4, 2016 / Lundin Law PC (the "Firm" announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU) concerning possible violations of federal securities laws between April 20, 2016 and June 2, 2016 (the "Class Period" . Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 8, 2016 lead plaintiff motion deadline.
IMMU: 3.27 (-0.03)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Immunomedics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016 - IMMU
GlobeNewswire - Wed Aug 03, 1:46PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
IMMU: 3.27 (-0.03)
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of a Class Action against Immunomedics Inc. (IMMU) and Lead Platintiff Deadline: August 8, 2016
ACCESSWIRE - Wed Aug 03, 9:38AM CDT
NEW YORK, NY / ACCESSWIRE / August 3, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of a class action against Immunomedics, Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU). The class action has been filed in the United States District Court, District of New Jersey, on behalf of a class consisting of all persons or entities who purchased Immunomedics common stock between April 20, 2016 and June 2, 2016 inclusive (the "Class Period" .
IMMU: 3.27 (-0.03)
AUGUST 8, 2016 DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Tue Aug 02, 5:24PM CDT
IRVINE, CA / ACCESSWIRE / August 2, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (Nasdaq: IMMU). Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive (the "Class Period" , are encouraged to contact the Firm prior to the August 8, 2016 lead plaintiff motion deadline.
IMMU: 3.27 (-0.03)
Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important August 8 Deadline in Class Action - IMMU
GlobeNewswire - Tue Aug 02, 12:51PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Immunomedics, Inc. securities (NASDAQ:IMMU) from April 20, 2016 through June 2, 2016, both dates inclusive (the "Class Period" of the important August 8, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Immunomedics investors under the federal securities laws.
IMMU: 3.27 (-0.03)
INVESTOR ALERT: Hagens Berman Reminds Immunomedics, Inc. (NASDAQ: IMMU) Investors of August 8, 2016 Lead Plaintiff Deadline
Marketwire Canada - Mon Aug 01, 8:30AM CDT
SAN FRANCISCO, CA--(Marketwired - August 01, 2016) - Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds Immunomedics, Inc. (NASDAQ: IMMU) investors of the August 8, 2016 Lead Plaintiff deadline in the securities class action filed in the United States District Court for the District of New Jersey.
IMMU: 3.27 (-0.03)
IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jul 29, 10:11AM CDT
IRVINE, CA / ACCESSWIRE / July 29, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU). Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive (the "Class Period" , are encouraged to contact the Firm prior to the August 8, 2016, lead plaintiff motion deadline.
IMMU: 3.27 (-0.03)
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Immunomedics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016
BusinessWire - Fri Jul 29, 8:35AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
IMMU: 3.27 (-0.03)
Brower Piven Alerts Shareholders of Upcoming Deadline in Class Action Lawsuit and Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Immunomedics, Inc. to Contact the Firm - IMMU
GlobeNewswire - Thu Jul 28, 2:45PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Immunomedics, Inc. (Nasdaq:IMMU) ("Immunomedics" or the "Company" securities during the period between April 20, 2016 and June 3, 2016, inclusive (the "Class Period" . Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until August 8, 2016 to seek appointment as lead plaintiff.
IMMU: 3.27 (-0.03)
SHAREHOLDER ALERT: Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important Deadline in Class Action - IMMU
BusinessWire - Thu Jun 23, 2:34PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Immunomedics, Inc. securities (NASDAQ:IMMU) from April 20, 2016 through June 2, 2016, both dates inclusive (the "Class Period" of the important August 8, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Immunomedics investors under the federal securities laws.
IMMU: 3.27 (-0.03)
How These Biotech Stocks are Faring? -- Immunomedics, Sequenom, INSYS Therapeutics, and Regulus Therapeutics
PR Newswire - Thu Sep 08, 6:59AM CDT
Biotechnology is well known for cycling between booms and busts, making it both an interesting and intimidating space to navigate. It is a place where investors either come out soaring to the top or the other way around. This morning, Stock-Callers.com directs its attention to the following equities: Immunomedics Inc. (NASDAQ: IMMU), Sequenom Inc. (NASDAQ: SQNM), INSYS Therapeutics Inc. (NASDAQ: INSY), and Regulus Therapeutics Inc. (NASDAQ: RGLS). Register now and get full and free access to our downloadable research reports on these stocks at: http://stock-callers.com/registration
INSY: 12.56 (-0.32), SQNM: 2.39 (-0.01), IMMU: 3.27 (-0.03), RGLS: 3.45 (+0.03)
Immunomedics to Present at Upcoming Investor Conferences
GlobeNewswire - Wed Aug 31, 6:00AM CDT
Immunomedics, Inc. (Nasdaq:IMMU) today announced that the Company will present at three upcoming investor conferences:
IMMU: 3.27 (-0.03)
Preclinical Study on Enhancing Sacituzumab Govitecan (IMMU-132) Activity in SN-38-Resistant Cancer Cells Published
GlobeNewswire - Thu Aug 18, 6:00AM CDT
Immunomedics, Inc. (Nasdaq:IMMU) today announced that adding an inhibitor of ATP-binding cassette (ABC) transporters to sacituzumab govitecan, the Company's lead antibody-drug conjugate (ADC) for solid cancer therapy, increased the median survival of mice bearing a SN-38-resistant human gastric cancer cell line. Results from this preclinical study were published in Molecular Cancer Therapeutics.
IMMU: 3.27 (-0.03)
Immunomedics Announces Conference Call And Webcast For Fourth Quarter And Fiscal Year 2016 Financial Results
GlobeNewswire - Thu Aug 11, 6:00AM CDT
Immunomedics, Inc., (Nasdaq:IMMU) today announced that it will host a conference call and live audio webcast on Wednesday, August 17, 2016 at 5:00 p.m. Eastern Time to discuss financial results for the fourth quarter and fiscal year 2016, and review key clinical developments and future planned activities.
IMMU: 3.27 (-0.03)
DEADLINE TODAY: Khang & Khang LLP Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Aug 08, 10:03AM CDT
IRVINE, CA / ACCESSWIRE / August 8, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU). Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive (the "Class Period" , are encouraged to contact the Firm prior to the August 8, 2016, lead plaintiff motion deadline. IMMU: 3.27 (-0.03)
FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics Inc. (IMMU) and Lead Plaintiff Deadline - August 8, 2016
ACCESSWIRE - Mon Aug 08, 9:16AM CDT
NEW YORK, NY / ACCESSWIRE / August 8, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against of Immunomedics, Inc. ("Immunomedics" or the "Company"
(NASDAQGM: IMMU). The class action has been filed in the United States District Court, District of New Jersey, on behalf of a class consisting of all persons or entities who purchased Immunomedics common stock between April 20, 2016 and June 2, 2016 inclusive (the "Class Period" . IMMU: 3.27 (-0.03)
IMMUNOMEDICS 72 HOUR DEADLINE ALERT: APPROXIMATELY 72 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS of Deadline in Class Action Lawsuit Against Immunomedics Inc. - IMMU
GlobeNewswire - Fri Aug 05, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF"
and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until August 8, 2016 to file lead plaintiff applications in a securities class action lawsuit against Immunomedics Inc. (Nasdaq:IMMU). Investor losses must relate to purchases of the Company's securities between April 20, 2016 and June 2, 2016. This action is pending in the United States District Court for the District of New Jersey. IMMU: 3.27 (-0.03)
APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Aug 04, 10:44AM CDT
LOS ANGELES, CA / ACCESSWIRE / August 4, 2016 / Lundin Law PC (the "Firm"
announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU) concerning possible violations of federal securities laws between April 20, 2016 and June 2, 2016 (the "Class Period" . Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 8, 2016 lead plaintiff motion deadline. IMMU: 3.27 (-0.03)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Immunomedics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016 - IMMU
GlobeNewswire - Wed Aug 03, 1:46PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
IMMU: 3.27 (-0.03)
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of a Class Action against Immunomedics Inc. (IMMU) and Lead Platintiff Deadline: August 8, 2016
ACCESSWIRE - Wed Aug 03, 9:38AM CDT
NEW YORK, NY / ACCESSWIRE / August 3, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of a class action against Immunomedics, Inc. ("Immunomedics" or the "Company"
(NASDAQ: IMMU). The class action has been filed in the United States District Court, District of New Jersey, on behalf of a class consisting of all persons or entities who purchased Immunomedics common stock between April 20, 2016 and June 2, 2016 inclusive (the "Class Period" . IMMU: 3.27 (-0.03)
AUGUST 8, 2016 DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Tue Aug 02, 5:24PM CDT
IRVINE, CA / ACCESSWIRE / August 2, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (Nasdaq: IMMU). Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive (the "Class Period" , are encouraged to contact the Firm prior to the August 8, 2016 lead plaintiff motion deadline. IMMU: 3.27 (-0.03)
Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important August 8 Deadline in Class Action - IMMU
GlobeNewswire - Tue Aug 02, 12:51PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Immunomedics, Inc. securities (NASDAQ:IMMU) from April 20, 2016 through June 2, 2016, both dates inclusive (the "Class Period"
of the important August 8, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Immunomedics investors under the federal securities laws. IMMU: 3.27 (-0.03)
INVESTOR ALERT: Hagens Berman Reminds Immunomedics, Inc. (NASDAQ: IMMU) Investors of August 8, 2016 Lead Plaintiff Deadline
Marketwire Canada - Mon Aug 01, 8:30AM CDT
SAN FRANCISCO, CA--(Marketwired - August 01, 2016) - Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds Immunomedics, Inc. (NASDAQ: IMMU) investors of the August 8, 2016 Lead Plaintiff deadline in the securities class action filed in the United States District Court for the District of New Jersey.
IMMU: 3.27 (-0.03)
IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jul 29, 10:11AM CDT
IRVINE, CA / ACCESSWIRE / July 29, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU). Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive (the "Class Period" , are encouraged to contact the Firm prior to the August 8, 2016, lead plaintiff motion deadline. IMMU: 3.27 (-0.03)
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Immunomedics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016
BusinessWire - Fri Jul 29, 8:35AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
IMMU: 3.27 (-0.03)
Brower Piven Alerts Shareholders of Upcoming Deadline in Class Action Lawsuit and Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Immunomedics, Inc. to Contact the Firm - IMMU
GlobeNewswire - Thu Jul 28, 2:45PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Immunomedics, Inc. (Nasdaq:IMMU) ("Immunomedics" or the "Company"
securities during the period between April 20, 2016 and June 3, 2016, inclusive (the "Class Period" . Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until August 8, 2016 to seek appointment as lead plaintiff. IMMU: 3.27 (-0.03)
SHAREHOLDER ALERT: Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important Deadline in Class Action - IMMU
BusinessWire - Thu Jun 23, 2:34PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Immunomedics, Inc. securities (NASDAQ:IMMU) from April 20, 2016 through June 2, 2016, both dates inclusive (the "Class Period"
of the important August 8, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Immunomedics investors under the federal securities laws. IMMU: 3.27 (-0.03)
(0)
(0)Scroll down for more posts ▼